HiSeq X Ten, PacBio Sequel, and 10x Genomics Added to Line-up
SOUTH PLAINFIELD, N.J. and NEW ORLEANS — (AACR16, Booth #2241) — GENEWIZ, a leading global genomics services provider, announced today it has acquired multiple high-throughput sequencing (also known as Next Generation Sequencing (NGS)) platforms including the Illumina HiSeq X Ten, PacBio Sequel, and 10x Genomics Chromium. The addition of these cutting-edge systems strengthens the scope of the NGS services GENEWIZ offers the scientific community worldwide.
“Our purchase of the X Ten, the sequencing system with the highest throughput, allows our customers access to an unprecedented scale of whole genome sequencing (WGS) for species of all types including human, animal, plant and beyond,” said Dr. Steve Sun, GENEWIZ CEO. “Additionally, the PacBio Sequel for long-read, single molecules and the 10x Genomics system for single cell sequencing will make GENEWIZ a complete solution provider for all NGS projects.”
These new platforms complement GENEWIZ’s existing HiSeq, MiSeq, and Ion Torrent platforms providing a variety of sequencing read lengths and throughput options to accommodate all kinds of research and application needs for different project costs and timelines. The strength of these diverse platform capabilities combined with GENEWIZ’s powerful bioinformatics services will allow research scientists worldwide to efficiently advance their discoveries.
“After the successful acquisition of Beckman Coulter Genomics business, this investment in these new powerful machines reinforces GENEWIZ’s position as a global leader in genomics services. Our customers will continue to enjoy the most advanced technology, highest quality and unsurpassed services provided by our dedicated team,” added Dr. Sun.
Source – PRNewswire